ruthenium has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryszewska, M; de la Mata, FJ; Denel, M; Ionov, M; Jacenik, D; Michlewska, S; Ortega, P; Rogalska, A; Sanz Del Olmo, N; Shcharbin, D; Szwed, A | 1 |
1 other study(ies) available for ruthenium and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Comet Assay; Dendrimers; Gene Expression Regulation, Leukemic; Humans; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Ruthenium | 2020 |